Special Coagulation Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Special Coagulation Tests Pipeline Market Report Overview

Special coagulation tests are reagents that are used to conduct special coagulation tests which provide a quantitative determination of anticoagulant activities of heparin and thrombin formation.

The special coagulation tests pipeline market research report provides comprehensive information about the special coagulation tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Territories The US, and Canada
Key Regulatory Paths 510(k), and MDL
Leading Companies Diagnostica Stago Inc, Helena Laboratories Corp, Instrumentation Laboratory Co, Massachusetts General Hospital, Roche Diagnostics International Ltd, Siemens Healthcare Diagnostics GmbH, Siemens Healthcare Diagnostics Inc, and SQI Diagnostics Inc
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Special Coagulation Tests Pipeline Market Segmentation by Territories

Some of the territories in the special coagulation tests market are the United States (US), and Canada among others. As of June 2023, the United States had the highest number of pipeline products.

Special Coagulation Tests Pipeline Market Analysis, by Territories, 2023 (%)

Special Coagulation Tests Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the special coagulation tests pipeline market, download a free report sample

Special Coagulation Tests Pipeline Market Segmentation by Regulatory Paths

Some of the regulatory paths in the special coagulation tests pipeline market are 510(k), and MDL among others. As of June 2023, 510(k) was the most followed pathway for pipeline products.

Special Coagulation Tests Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Special Coagulation Tests Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the special coagulation tests pipeline market, download a free report sample

Special Coagulation Tests Pipeline Market – Competitive Landscape

Some of the key companies in the special coagulation tests pipeline market are Diagnostica Stago Inc, Helena Laboratories Corp, Instrumentation Laboratory Co, Massachusetts General Hospital, Roche Diagnostics International Ltd, Siemens Healthcare Diagnostics GmbH, Siemens Healthcare Diagnostics Inc, and SQI Diagnostics Inc among others.

Diagnostica Stago Inc: Diagnostica Stago Inc (Stago), a subsidiary of Diagnostica Stago SAS, is a medical device company that develops and distributes in-vitro diagnostic products. It develops coagulation automation systems. It provides products such as hemostasis analyzers, viscosity based detection systems, reagents and research products. Stago’s research and reagent products includes venoms, activators, purified proteins, coagulation factors, inhibitors, chromogenic substrates, lupus inhibitors, heparin anti-xa assays, coagulation inhibitors, fibrin and fibrinogen degradation products, among others. The company offers various customer services such as proficiency testing, field technical support, education and customer training. It also offers hemostasis proficiency testing program and peer group program. The company operates in the US and Canada. Stago is headquartered in Parsippany, New Jersey, the US.

Segments Covered in the Report

Special Coagulation Tests Pipeline Market Territories Outlook

  • The US
  • Canada
  • Global

Special Coagulation Tests Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • MDL

Scope

  • Extensive coverage of the special coagulation tests under development
  • Reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities
  • Reviews the major players involved in the development of special coagulation tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with the potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of special coagulation tests under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Diagnostica Stago Inc
Helena Laboratories Corp
Instrumentation Laboratory Co
Massachusetts General Hospital
Roche Diagnostics International Ltd
Siemens Healthcare Diagnostics GmbH
Siemens Healthcare Diagnostics Inc
SQI Diagnostics Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 4

|1.2 List of Figures 6

2 Introduction 7

2.1 Special Coagulation Tests Overview 7

3 Products under Development 8

3.1 Special Coagulation Tests – Pipeline Products by Stage of Development 8

3.2 Special Coagulation Tests – Pipeline Products by Territory 9

3.3 Special Coagulation Tests – Pipeline Products by Regulatory Path 10

3.4 Special Coagulation Tests – Pipeline Products by Estimated Approval Date 11

4 Special Coagulation Tests – Pipeline Products under Development by Companies 12

4.1 Special Coagulation Tests Companies – Pipeline Products by Stage of Development 12

4.2 Special Coagulation Tests – Pipeline Products by Stage of Development 13

5 Special Coagulation Tests Companies and Product Overview 14

5.1 Diagnostica Stago Inc Company Overview 14

5.1.1 Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview 14

5.2 Helena Laboratories Corp Company Overview 21

5.2.1 Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview 21

5.3 Instrumentation Laboratory Co Company Overview 25

5.3.1 Instrumentation Laboratory Co Pipeline Products & Ongoing Clinical Trials Overview 25

5.4 Massachusetts General Hospital Company Overview 30

5.4.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 30

5.5 Roche Diagnostics International Ltd Company Overview 31

5.5.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

5.6 Siemens Healthcare Diagnostics GmbH Company Overview 34

5.6.1 Siemens Healthcare Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 34

5.7 Siemens Healthcare Diagnostics Inc Company Overview 36

5.7.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.8 SQI Diagnostics Inc Company Overview 38

5.8.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 38

6 Special Coagulation Tests- Recent Developments 39

6.1 May 30, 2023: SQI Diagnostics reports second quarter 2023 results 39

6.2 Aug 29, 2022: SQI Diagnostics Reports Third Quarter 2022 Results 40

6.3 Jul 25, 2022: Beckman Coulter partners with Mass General and BARDA to identify severe pediatric infections in emergency departments 41

7 Appendix 43

7.1 Methodology 43

7.2 About GlobalData 46

7.3 Contact Us 46

7.4 Disclaimer 46

Table

Special Coagulation Tests – Pipeline Products by Stage of Development 8

Special Coagulation Tests – Pipeline Products by Territory 9

Special Coagulation Tests – Pipeline Products by Regulatory Path 10

Special Coagulation Tests – Pipeline Products by Estimated Approval Date 11

Special Coagulation Tests Companies – Pipeline Products by Stage of Development 12

Special Coagulation Tests – Pipeline Products by Stage of Development 13

Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview 14

STA Compact Max – NeoPTimal ISI – Product Status 14

STA Compact Max – NeoPTimal ISI – Product Description 15

STA Compact Max – Ristocetin Cofactor Assay – Product Status 15

STA Compact Max – Ristocetin Cofactor Assay – Product Description 15

STA Compact Max – Rivaroxaban Calibrators And Controls For Anti-Xa – Product Status 16

STA Compact Max – Rivaroxaban Calibrators And Controls For Anti-Xa – Product Description 16

STA-R Evolution Expert – Automated Ecarin Chromogenic Assay – Product Status 16

STA-R Evolution Expert – Automated Ecarin Chromogenic Assay – Product Description 17

STA-R Evolution Plus – Automated Ecarin Chromogenic Assay – Product Status 17

STA-R Evolution Plus – Automated Ecarin Chromogenic Assay – Product Description 17

STA-R Evolution Plus – Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa – Product Status 18

STA-R Evolution Plus – Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa – Product Description 18

STA-R Max – NeoPTimal ISI – Product Status 18

STA-R Max – NeoPTimal ISI – Product Description 19

STA-R Max – Ristocetin Cofactor Assay – Product Status 19

STA-R Max – Ristocetin Cofactor Assay – Product Description 19

STA-R Max – Rivaroxaban Calibrators And Controls For Anti-Xa – Product Status 20

STA-R Max – Rivaroxaban Calibrators And Controls For Anti-Xa – Product Description 20

Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview 21

Actalyke Mini II – LMWH Test – Product Status 21

Actalyke Mini II – LMWH Test – Product Description 21

Actalyke XL – Heparin Test – Product Status 22

Actalyke XL – Heparin Test – Product Description 22

Actalyke XL – LMWH Test – Product Status 22

Actalyke XL – LMWH Test – Product Description 23

Cascade M – DRVVT Test – Product Status 23

Cascade M – DRVVT Test – Product Description 23

Cascade M-4 – DRVVT Test – Product Status 23

Cascade M-4 – DRVVT Test – Product Description 24

Instrumentation Laboratory Co Pipeline Products & Ongoing Clinical Trials Overview 25

ACL AcuStar – VWF: RCo Assay – Product Status 25

ACL AcuStar – VWF: RCo Assay – Product Description 26

ACL TOP 300 CTS System – Global Protein C Pathway Test – Product Status 26

ACL TOP 300 CTS System – Global Protein C Pathway Test – Product Description 26

ACL TOP 500 CTS System – Global Protein C Pathway Test – Product Status 27

ACL TOP 500 CTS System – Global Protein C Pathway Test – Product Description 27

ACL TOP 700 System – Global Protein C Pathway Test – Product Status 27

ACL TOP 700 System – Global Protein C Pathway Test – Product Description 27

HemosIL ACL AcuStar – VWF:Ag Assay – Product Status 28

HemosIL ACL AcuStar – VWF:Ag Assay – Product Description 28

HemosIL VWF-Ristocetin Cofactor Activity Assay – Product Status 28

HemosIL VWF-Ristocetin Cofactor Activity Assay – Product Description 29

Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 30

High Throughput Screening Assay – Fibrin-Binding Probes – Product Status 30

High Throughput Screening Assay – Fibrin-Binding Probes – Product Description 30

Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

Cobas t 511 Coagulation Analyzer – dRVVT Confirm Assay – Product Status 31

Cobas t 511 Coagulation Analyzer – dRVVT Confirm Assay – Product Description 31

Cobas t 511 Coagulation Analyzer – dRVVT Screen Assay – Product Status 32

Cobas t 511 Coagulation Analyzer – dRVVT Screen Assay – Product Description 32

Cobas t 711 Coagulation Analyzer – dRVVT Confirm Assay – Product Status 32

Cobas t 711 Coagulation Analyzer – dRVVT Confirm Assay – Product Description 32

Cobas t 711 Coagulation Analyzer – dRVVT Screen Assay – Product Status 33

Cobas t 711 Coagulation Analyzer – dRVVT Screen Assay – Product Description 33

Siemens Healthcare Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 34

Atellica COAG 360 System – Berichrom C-1 Inhibitor Assay – Product Status 34

Atellica COAG 360 System – Berichrom C-1 Inhibitor Assay – Product Description 34

INNOVANCE DTI Assay – Product Status 35

INNOVANCE DTI Assay – Product Description 35

Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Sysmex CS-2500 System – Von Willebrand Factor Test – Product Status 36

Sysmex CS-2500 System – Von Willebrand Factor Test – Product Description 36

Sysmex CS-5100 System – Von Willebrand Factor Assay – Product Status 37

Sysmex CS-5100 System – Von Willebrand Factor Assay – Product Description 37

SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 38

IgXPlex – HIT Assay – Product Status 38

IgXPlex – HIT Assay – Product Description 38

Glossary 45

Figures

Special Coagulation Tests – Pipeline Products by Stage of Development 8

Special Coagulation Tests – Pipeline Products by Territory 9

Special Coagulation Tests – Pipeline Products by Regulatory Path 10

Special Coagulation Tests – Pipeline Products by Estimated Approval Date 11

Frequently asked questions

Special Coagulation Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Special Coagulation Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Special Coagulation Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Special Coagulation Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.